Evidence map›Paper›PMID 34243810›Full record

ArticleGenome biology2021

Elevated retrotransposon activity and genomic instability in primed pluripotent stem cells.

Haifeng Fu, Weiyu Zhang, Niannian Li, Jiao Yang, Xiaoying Ye, Chenglei Tian, Xinyi Lu, Lin Liu

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Haifeng Fu *State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.
Weiyu Zhang *State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.
Niannian Li *State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.
Jiao Yang *State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.
Xiaoying YeState Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.
Chenglei TianState Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.
Xinyi LuState Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.
Lin LiuState Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China. liulin@nankai.edu.cn.ORCID 0000-0001-9881-6830
Nankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNaïve and primed pluripotent stem cells (PSCs) represent two different pluripotent states. Primed PSCs following in vitro culture exhibit lower developmental potency as evidenced by failure in germline chimera assays, unlike mouse naïve PSCs. However, the molecular mechanisms underlying the lower developmental competency of primed PSCs remain elusive.

resultsWe examine the regulation of telomere maintenance, retrotransposon activity, and genomic stability of primed PSCs and compare them with naïve PSCs. Surprisingly, primed PSCs only minimally maintain telomeres and show fragile telomeres, associated with declined DNA recombination and repair activity, in contrast to naïve PSCs that robustly elongate telomeres. Also, we identify LINE1 family integrant L1Md_T as naïve-specific retrotransposon and ERVK family integrant IAPEz to define primed PSCs, and their transcription is differentially regulated by heterochromatic histones and Dnmt3b. Notably, genomic instability of primed PSCs is increased, in association with aberrant retrotransposon activity.

conclusionsOur data suggest that fragile telomere, retrotransposon-associated genomic instability, and declined DNA recombination repair, together with reduced function of cell cycle and mitochondria, increased apoptosis, and differentiation properties may link to compromised developmental potency of primed PSCs, noticeably distinguishable from naïve PSCs.

Indexed as

Genomic InstabilityProtein Processing, Post-TranslationalRetroelementsTelomere HomeostasisActivinsAnimalsApoptosisCell CycleCell DifferentiationDNADNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3BFibroblast Growth Factor 2HeterochromatinHistonesMiceactivin AActivinsDNADNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3BFibroblast Growth Factor 2HeterochromatinHistonesRetroelements2C genesGenome stabilityHistone modificationsNaïve and primed pluripotent stateRetrotransposonsTelomeres

Identifiers

PMID34243810
PMCPMC8268579
OpenAlexW3182822735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.